Beta-nerve growth factor (beta-NGF) mRNA expression in the parkinsonian adrenal gland

Exp Neurol. 1991 Aug;113(2):166-70. doi: 10.1016/0014-4886(91)90172-9.

Abstract

The adrenal gland is a well-demonstrated source for different neurotrophic factors. The presence of the beta-nerve growth factor (beta-NGF) mRNA in the adrenal tissue used for grafting in a Parkinsonian patient is reported here. Adrenal samples were obtained on the day of implantation, and a specific cDNA was synthesized after the extraction of total RNA using a synthetic oligonucleotide as a reverse transcription primer. A 168-bp portion of the cDNA was amplified using two other oligonucleotides as Taq polymerase primers in a polymerase chain reaction. Thirty-two cycles of amplification were performed. The amplification products were identified by agarose gel electrophoresis and Southern blot analysis as a single DNA band hybridizing with a third beta-NGF specific oligonucleotide. The identity of the fragment was confirmed by DNA sequencing. Quantitative analysis demonstrated a beta-NGF mRNA concentration exceeding 5 fg/micrograms of total adrenal RNA. These findings add NGF to the other neurotrophic factors produced by the gland (i.e., basic fibroblast growth factor) and demonstrate the retained functional capacity of the Parkinsonian adrenal to express the beta-NGF mRNA. All these data may assume relevant meaning for neurotransplantation research.

Publication types

  • Case Reports
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adrenal Glands / metabolism*
  • Adrenal Glands / transplantation
  • Base Sequence
  • Brain / physiopathology
  • DNA / genetics
  • Humans
  • Male
  • Middle Aged
  • Nerve Growth Factors / genetics*
  • Parkinson Disease / metabolism*
  • Parkinson Disease / physiopathology
  • Parkinson Disease / therapy
  • Polymerase Chain Reaction
  • RNA, Messenger / metabolism*

Substances

  • Nerve Growth Factors
  • RNA, Messenger
  • DNA